ReviewInnere Medizin (Heidelberg, Germany)2025
[Preventing frailty and maintaining good health during aging].
Review in Innere Medizin (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prediction of frailty in community older adults based on machine learning: a systematic review and meta-analysis.Frontiers in public health · 2025Pooled it
- Regional Variation in the Prevalence of Frailty Among Very Old Adults in Germany: Findings of the Nationwide Study "Old Age in Germany" (D80+).Deutsches Arzteblatt international · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Frailty is an established clinical syndrome that occurs more frequently with increasing age, but also often contributes to irreversible functional loss in younger adults. Its multidimensional, complex pathophysiology and phenotypic nature is associated with atypical disease presentation and underdiagnosis in clinical routine. The latter still utilizes, especially in nongeriatric settings, medical technologies that are often unable to capture and measure frailty. In addition, frailty progresses per se rather imperceptibly until its late stages, when it is too close to the point of no return and difficult to treat efficiently. Therefore, prevention of frailty is key in the context demographic change, characterized by socioeconomically unsustainable rates of multimorbidity and disability. In the framework of the present special issue, this contribution aims at highlighting relevance, potential, and methodology of frailty prevention for the maintenance of function and vitality during life.
Indexed as
Identifiers
40864248What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.